NCT03309943View on ClinicalTrials.gov

Neurobehavioral Substrates of Propranolol's Effects on Drug Cue Reactivity

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

July 15, 2019

Study Completion Date

July 15, 2019

Conditions
Cigarette Smoking
Interventions
DRUG

Propranolol

Participants will take one dose of Propranolol (40mg IR) on two separate occasions.

DRUG

Placebo

Participants will take one dose of Placebo on two separate occasions.

Trial Locations (1)

27705

Duke University School of Medicine, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Duke University

OTHER

NCT03309943 - Neurobehavioral Substrates of Propranolol's Effects on Drug Cue Reactivity | Biotech Hunter | Biotech Hunter